Stay updated on Clinical Trial: SAR650984 Combo in NDMM Non-Transplant Eligible
Sign up to get notified when there's something new on the Clinical Trial: SAR650984 Combo in NDMM Non-Transplant Eligible page.

Latest updates to the Clinical Trial: SAR650984 Combo in NDMM Non-Transplant Eligible page
- Check5 days agoChange DetectedThe record now displays details for the IMROZ Phase 3 multiple myeloma trial, including its design, treatments, eligibility criteria, outcome measures, and participating locations. It also includes publications, study dates, and information about sharing participant data.SummaryDifference100%

- Check12 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAn NIH-wide notice about using “Super Intelligence” in place of “Artificial Intelligence” appears above the page, while the study record still shows a 403 error. The site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check40 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1 while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now displays a 403 Forbidden error page, replacing the prior study content. This indicates that access to the study record is blocked.SummaryDifference19%

- Check61 days agoChange DetectedRevision: v3.7.0 was added to the page footer, replacing the previous Revision: v3.6.6. This reflects an update to the page's build/version tagging without altering the displayed study details.SummaryDifference0.0%

Stay in the know with updates to Clinical Trial: SAR650984 Combo in NDMM Non-Transplant Eligible
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: SAR650984 Combo in NDMM Non-Transplant Eligible page.